ATE217023T1 - Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen - Google Patents

Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen

Info

Publication number
ATE217023T1
ATE217023T1 AT96934660T AT96934660T ATE217023T1 AT E217023 T1 ATE217023 T1 AT E217023T1 AT 96934660 T AT96934660 T AT 96934660T AT 96934660 T AT96934660 T AT 96934660T AT E217023 T1 ATE217023 T1 AT E217023T1
Authority
AT
Austria
Prior art keywords
sdi
retroviral vectors
antisense
vectors carrying
inhibitors
Prior art date
Application number
AT96934660T
Other languages
English (en)
Inventor
Walter H Guenzburg
Robert Michael Saller
Brian Salmons
Original Assignee
Austrian Nordic Biotherapeutic
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutic, Gsf Forschungszentrum Umwelt filed Critical Austrian Nordic Biotherapeutic
Application granted granted Critical
Publication of ATE217023T1 publication Critical patent/ATE217023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96934660T 1995-10-13 1996-10-11 Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen ATE217023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK115795 1995-10-13
PCT/EP1996/004447 WO1997013867A1 (en) 1995-10-13 1996-10-11 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences

Publications (1)

Publication Number Publication Date
ATE217023T1 true ATE217023T1 (de) 2002-05-15

Family

ID=8101648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934660T ATE217023T1 (de) 1995-10-13 1996-10-11 Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen

Country Status (7)

Country Link
EP (1) EP0859854B1 (de)
AT (1) ATE217023T1 (de)
AU (1) AU7291696A (de)
DE (1) DE69621035T2 (de)
DK (1) DK0859854T3 (de)
ES (1) ES2176500T3 (de)
WO (1) WO1997013867A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139817A (en) * 1996-10-15 2000-10-31 Smithkline Beecham Corporation Method for determining gene essentiality in a pathogen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302706A (en) * 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
CA2170641C (en) * 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
WO1995013375A1 (en) * 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
JP4037446B2 (ja) * 1994-09-02 2008-01-23 ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 非自己不活化性の発現標的化レトロウイルスベクタ
US5863904A (en) * 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21

Also Published As

Publication number Publication date
DE69621035T2 (de) 2003-01-02
ES2176500T3 (es) 2002-12-01
DE69621035D1 (de) 2002-06-06
AU7291696A (en) 1997-04-30
EP0859854A1 (de) 1998-08-26
DK0859854T3 (da) 2002-08-19
WO1997013867A1 (en) 1997-04-17
EP0859854B1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
NO962991D0 (no) Zink-finger-proteinderivater og fremgangsmåter
PT1027440E (pt) Proteína inibidora da via de sinal wnt
ES557116A0 (es) Procedimiento para la obtencion de compuestos de desulfatohirudina
NO954722L (no) Peptid inhibitorer med urokinase reseptoraktivitet
MY102127A (en) Attrition resistant catalysts, catalyst precursors catalyst supports.
ATE440863T1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhíhung von einer entzündungsreaktion
DK0958353T3 (da) Phytase polypeptider
ATE389023T1 (de) Kontrolle der schotendehiszenz
HUP9802681A1 (hu) Onkogénnel vagy vírussal szabályozott expressziós rendszerek
EP1509251A4 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
ATE151310T1 (de) Epoxyolierungskatalysator
KR950032622A (ko) 전사 인자 에이피알에프(aprf)
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
ATE217023T1 (de) Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
ATE362540T1 (de) Kontrolle der pflanzlichen abszission und schotendehiszenz oder schotenabwurfs
ATE284960T1 (de) Nukleotid sequenzen kodierend für das lysr3 gen
KR960702849A (ko) 사람유래 종양세포 증식저해 인자
ES8607393A1 (es) Utilizacion de una secuencia de adn para la expresion, asi como estructura de adn y vector de expresion con la secuen- cia de adn
DE69418050D1 (de) Antivirale analoge von difluorostaton
EP0218432A3 (de) Verfahren zur Klonierung von cDNS und darin zu verwendende Vektor-Primär-DNS, Plasmid-DNS und Verknüpfungs-DNS
Millican SYNTHESIS AND BIOPHYSICAL EVALUATION OF 2-DEOXYNUCLEOSIDE ANALOGUES.
DE59000897D1 (de) Reaktor zur durchfuehrung katalytischer gasreaktionen bzw. physikalischer trennoperationen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee